Pioglitazone hydrochloride in combination with clomiphen citrate (CC) in ovulation and pregnancy induction among patients with polycystic ovary syndrome: A randomized, placebo controlled study

Hormozgan University of Medical Science0 个研究点目标入组 49 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Patients with history of anovulatory cycles during the past two months in addition to one of the following conditions:Serum progestrone level less than 5 mg during the mid-luteal phase; Hirsutism; Positive response to medroxy-progesterone acetate withdrawal test; Serum testosterone level higher than 65 Ng/Dl
•Exclusion criteria; patients with confirmed diabetes mellitus or fasting blood glucose higher than 125 mg/dl; congenital adrenal hyperplasia which was confirmed by 17-alpha hydroxy progesterone level of 200 ng/dl or higher; patients with underlying disorders such as thyroid disease; hyperprolactinemia; congenital heart disease; hypertension; renal and liver dysfunction; patients who had received any hypoglycemic agent or inducing ovulation medications during 30days ago.

发起方

Hormozgan University of Medical Science